Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > B7-33 2mg/5mg/10mg for Sale > B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - large image1
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - image1
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - image2
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - image3
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - image4
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - image5
B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization buy - image6

B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization

TDS 4 Inquiries

Unit Price: Get Latest Price
CAS No.:

1818415-56-3

Grade:

Pharmaceutical Grade

Content:

99.999%

Port:

shenzhen

Packaging:

2mg*10vials 10mg*10vials

Price valid (until):

2026-09-30

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
1 days
Qualification:
Main Products:

Tirzepatide,Retatrutide,Semaglutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    What is Retatrutide?


    Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor . Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides. Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.

    Function

    1. 1.Treatment of depression and anxiety disorders:  Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
    2. 2.Prevention of neurodegenerative diseases:  Retatrutide  has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
    3. 3.Enhancement of cognitive function:  Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
    4. 4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
    5. 5.Promotion of wound healing:  Retatrutide  has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.

    Application

    1. Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
    2. Retatrutide is a kind of peptide product.
    3. Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
    4. Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
    5. Retatrutide acetate can be used in studies of obesity.


    Shop B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization-Detailed Image 1 Shop B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization-Detailed Image 2

    Shipping and packages

    Shipping Cost: Special Shipping Line, delivery time 12-15 days
    USPS(to America), delivery time 10-12 days
    DHL/UPS/Fedex(Worldwild), delivery time 5-7 days
    Forwarder informs that due to the increased customs inspection and the increased difficulty of customs clearance, the logistics costs have increased. We have to make changes to the delivery clause. Once the logistics situation changes, we will update it as soon as possible. We hope you can understand.


    Shop In stock GHK-CU 89030-95-5 Copper tripeptide Door-to-door delivery, spot, high quality, high purity, free shipping-Detailed Image 11 Shop Weightloss peptide Tirzepatide Retatrutide AOD NAD BPC TB 5mg 10mg peptide vials-Detailed Image 12

    Items Specifications
    Appearance White to off-white powder
    Purity (HPLC) Not less than 99.0%
    Peptide Content Not less than 75.0%
    Goods quality:
    1.Product has COA, and HPLC testing report
    2.Our factory is ISO9001 standard
    3.We have the great reviews from customers

    OEM service:
    1.Customized logo
    2.Customized label, packing box as customer's requirement
    3.Cap color can be customized

    Shipping service:
    1.Goods shipped in 1-3 days after payment.
    2.Shipping fast and safe in about 5-10 days
    3.We can do special packing
    4.Tracking number is offered after ordering
    Door to door,Clearance,100% safe delivery to your hands
    If there is any problem in transportation, we are willing to bear all costs,

    Shop B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization-Detailed Image 5
    ECHEMI Editorial Reference
    B7-33 is a selective relaxin receptor 1 (RXFP1) agonist. It binds to RXFP1 and preferentially activates thepERK pathway over cAMP in cells (with RXFP1 expression).
    Research & Reference Note

    B7-33 99% High peptide content white powder High GLP/GLP-1 3mg 10mg customization is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates

    Basic Info
    Product Name:

    B7-33 2mg/5mg/10mg

    Other Name:

    B7-33 2mg/5mg/10mg;L-Leucinamide, L-valyl-L-isoleucyl-L-lysyl-L-leucyl-L-serylglycyl-L-arginyl-L-α-glutamyl-L-leucyl-L-valyl-L-arginyl-L-alanyl-L-glutaminyl-L-isoleucyl-L-alanyl-L-isoleucyl-L-serylglycyl-L-methionyl-L-seryl-L-threonyl-L-tryptophyl-L-seryl-L-lysyl-L-arginyl-L-seryl-;(B7-33)H2;B7-33 relaxin

    CAS No.:

    1818415-56-3

    Molecular Formula:

    C131H229N41O36S

    Molecular Weight:

    2986.54

    Characteristics
    Density:

    1.445±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,Semaglutide

    Location:

    Unit 1207, Elevator 1, Office Tower A2, Wanda Plaza, No. 8 Aojiang Road, Taijiang District, Fuzhou City, Fujian Province

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    1 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2024

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    B7-33

    10 MG Oct 15, 2026
    United Kingdom

    B7-33

    360 MG May 10, 2026
    Canada

    B7-33

    1  Aug 13, 2026
    United States

    B7-33

    200 MG Aug 13, 2025
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.